Skip to main content

Lymphoma Research Group

Understanding lymphomas for kinder, more effective treatments

We study the underlying molecular biology and tumour immune microenvironment (TIME) of lymphoma, particularly focusing on paediatric non-Hodgkin lymphomas (NHL). Combining cutting edge genomic technologies, molecular haematopathology and clinical outcome we are developing understanding of these rare tumours with the aim of identifying new diagnostic, prognostic and predictive biomarkers. Through integration with national and European consortia we have the goal of translating that learning into new treatment strategies for children, reducing toxicity and improving survival.

Prevention & Screening patient

Our research